Colestipol Hydrochloride
Colestipol Hydrochloride for Oral Suspension
Approved
Approval ID
4e89bf6e-c78a-402e-9cb2-8d02f6047d68
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 18, 2022
Manufacturers
FDA
Greenstone LLC
DUNS: 825560733
FDA
Mylan Pharmaceuticals Inc.
DUNS: 059295980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Colestipol Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code59762-0260
Application NumberNDA017563
Product Classification
M
Marketing Category
C73605
G
Generic Name
Colestipol Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 18, 2022
FDA Product Classification
INGREDIENTS (2)
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
COLESTIPOL HYDROCHLORIDEActive
Quantity: 5 g in 5 g
Code: X7D10K905G
Classification: ACTIB